Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-26 7:10 pm Purchase | 2026-02-19 | 13G | Capricor Therapeutics, Inc. CAPR | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,417,891 6.600% | 3,417,891 (New Position) | Filing History |
| 2026-02-13 4:50 pm Unchanged | 2025-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-02-13 4:49 pm Sale | 2025-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% | -648,832 (Position Closed) | Filing History |
| 2026-02-13 4:46 pm Purchase | 2025-12-31 | 13G | Zura Bio Limited ZURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,567,001 8.600% | 5,567,001 (New Position) | Filing History |
| 2026-02-13 4:41 pm Sale | 2025-12-31 | 13G | Immatics N.V. IMTX | SUVRETTA CAPITAL MANAGEMENT, LLC | 11,190,129 8.300% | -840,000 (-6.98%) | Filing History |
| 2026-02-13 4:32 pm Purchase | 2025-12-31 | 13G | InflaRx N.V. IFRX | SUVRETTA CAPITAL MANAGEMENT, LLC | 7,933,910 11.700% | 7,933,910 (New Position) | Filing History |
| 2026-02-13 4:27 pm Purchase | 2025-12-31 | 13G | Biohaven Ltd. BHVN | SUVRETTA CAPITAL MANAGEMENT, LLC | 10,286,937 7.800% | 10,286,937 (New Position) | Filing History |
| 2026-02-11 5:22 pm Purchase | 2026-02-05 | 13D | Veradermics, Incorporated MANE | SUVRETTA CAPITAL MANAGEMENT, LLC | 4,168,991 11.900% | 4,168,991 (New Position) | Filing History |
| 2025-11-13 5:31 pm Purchase | 2025-09-30 | 13G | Palvella Therapeutics, Inc. PVLA | SUVRETTA CAPITAL MANAGEMENT, LLC | 822,400 7.400% | 107,937 (+15.11%) | Filing History |
| 2025-11-13 5:24 pm Sale | 2025-09-30 | 13G | 89bio, Inc. ETNB | SUVRETTA CAPITAL MANAGEMENT, LLC | 8,280,000 5.600% | -6,331,409 (-43.33%) | Filing History |
| 2025-11-10 9:53 pm Purchase | 2025-11-07 | 13D | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | 17,761,945 44.100% | 2,138,286 (+13.69%) | Filing History |
| 2025-08-21 09:07 am Purchase | 2025-08-13 | 13G | Compass Therapeutics, Inc. CMPX | SUVRETTA CAPITAL MANAGEMENT, LLC | 14,101,159 8.200% | 6,951,666 (+97.23%) | Filing History |
| 2025-08-13 9:02 pm Sale | 2025-06-30 | 13G | PepGen Inc. PEPG | SUVRETTA CAPITAL MANAGEMENT, LLC | 300,000 0.900% | -1,360,932 (-81.94%) | Filing History |
| 2025-08-13 8:47 pm Purchase | 2025-06-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 648,832 7.700% | 648,832 (New Position) | Filing History |
| 2025-08-13 8:30 pm Purchase | 2025-06-30 | 13G | Immatics N.V. IMTX | SUVRETTA CAPITAL MANAGEMENT, LLC | 12,030,129 9.900% | 2,895,100 (+31.69%) | Filing History |
| 2025-08-13 8:21 pm Purchase | 2025-06-30 | 13G | Compass Therapeutics, Inc. CMPX | SUVRETTA CAPITAL MANAGEMENT, LLC | 7,149,493 5.200% | 7,149,493 (New Position) | Filing History |
| 2025-08-13 8:14 pm Purchase | 2025-06-30 | 13G | Erasca, Inc. ERAS | SUVRETTA CAPITAL MANAGEMENT, LLC | 14,502,004 5.100% | 2,187,000 (+17.76%) | Filing History |
| 2025-08-13 8:01 pm Purchase | 2025-06-30 | 13G | Aura Biosciences, Inc. AURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 4,701,775 7.600% | 1,644,456 (+53.79%) | Filing History |
| 2025-08-13 7:53 pm Purchase | 2025-06-30 | 13G | Abeona Therapeutics Inc. ABEO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,676,000 5.200% | 2,676,000 (New Position) | Filing History |
| 2025-08-13 7:29 pm Purchase | 2025-06-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,412,788 9.900% | 3,412,788 (New Position) | Filing History |